You are here
The Breakthrough Research Initiative to Develop Global Entrepreneurs
BRiDGE℠ engages Duke faculty, post-doctoral fellows and students to support the launch of new companies, and it develops entrepreneurial skill through mentorship.
Our goal is to provide a bridge for young startups to cross the entrepreneurial "valley of death" to arrive at a point at which they can attract private or public investment.
BRiDGE became a reality in 2018 thanks to a generous gift from Duke Engineering alumnus Alan L. Kaganov, and matching funds from the Pratt School of Engineering and the Duke Department of Biomedical Engineering.
"The challenge of bridging the funding gap that Duke Engineering startups faced resonated with my career experience. My wish for BRiDGE is that meaningful ideas will emerge and develop as fledgling companies."
Alan L. Kaganov '60
BRiDGE provides access to 2,000 square feet of lab and office space in The Chesterfield building, expert mentoring for company leaders, and an internship program for Duke Engineering students.
The Chesterfield is a life sciences and technology research facility in downtown Durham, North Carolina redeveloped from a former cigarette factory.
Our startup companies have access to:
- Leased lab benches in shared laboratory
- Leased cubicles
- Cell culture room
- Fume hood room
- Shared equipment rooms
- Shared offices and conference rooms
- Building amenities
Through partnership with Duke’s Innovation & Entrepreneurship Initiative and the Entrepreneurship @ Duke Engineering office, BRiDGE company leaders receive mentorship in the creation and refinement of their business plans.
This program provides summer internship opportunities to outstanding Duke Engineering students to obtain hands-on experience at new companies based in BRiDGE.
Applications for 2020 are being accepted now
BRiDGE engages Duke faculty, post-doctoral fellows and students to support the launch of new companies with the goal of developing a vibrant entrepreneurial ecosystem.
Applications are now being accepted on a rolling basis for the January to November 2020 cycle.
Building a patient-derived screening platform to increase the precision of personalized cancer therapies to overcome drug resistance after standard chemotherapy fails, with the added goal of developing a drug response database for cancer drug discovery. More »
Deep Blue Medical Advances
Developing a novel hernia mesh with integrated suture-like extensions that eliminates the key point of failure for conventional mesh fixation and provides superior anchor strength, to address the unacceptably high rate of hernia occurrence and recurrence. More »
Genetically engineering protein-based materials to mimic those naturally found in the environment—borrowing from nature’s toolbox. InSomaBio further modifies these proteins to assemble only with body heat, allowing complex cellular environments to be created with simple solution injections. More »
Developing IsoTag™ by fusing an antibody-binding domain to a stimulus responsive biopolymer, to provide a fast and inexpensive alternative to the current “gold” standard, protein A chromatography. More »
Developing coagulation time-monitoring devices and systems based on a technology invented at Zauscher Lab at Duke. This technology combines microfluidic systems with biosensors to enable extremely low sample volume requirements and on-chip pre-processing with many potential applications in the biomedical space. More »
Ramona Optics develops and sells computational microscope hardware and machine learning software for large field-of-view (300mm by 200mm), high resolution (5-10 micron) imaging. Ramona Optics’ optical microscopes provide gigapixel images in a small form factor, which opens up a variety of new applications in research, life sciences, and industry. More »